For generations, the pacemaker has meant surgery — a device buried beneath skin, wires threaded into the beating heart. Researchers at the University of Southern California and MIT have now demonstrated, in animal models, that sound itself may one day serve as the stimulus, using focused ultrasound to coax genetically modified heart cells into rhythm without a single incision. The work, published in Nature Biomedical Engineering, does not yet promise a clinical revolution, but it asks a question that medicine has rarely been positioned to ask: what if the most intimate interventions no longer
Scientists develop wearable ultrasound pacemaker that works without surgery
Sound waves become the stimulus instead of electricity
Mark
So they've built a pacemaker that sits on your chest and uses sound instead of electricity. How does that actually work?
Mimi
They genetically modified heart cells to respond to ultrasound. When the sound waves hit those modified cells, it triggers calcium to flow in, which makes the heart contract. It's a completely different mechanism from electrical pacing.
Luke
Wait—genetically modified. That's a big detail. How do you get those modified cells into a patient's heart in the first place?
Mimi
That's the part that's still unsolved. The animal tests used cells that were already modified. In a human, you'd need to either modify the patient's own cells or introduce modified cells somehow. That's a major hurdle.
Mark
They tested it in rats and pigs. Did it work?
Mimi
In rats with irregular heartbeats, yes—they restored normal rhythm. They also tested with pig tissue to see if it would work at a scale closer to human hearts. The precision was less than one millimetre.
Luke
But that's in a lab. The heart moves, it's covered by tissue. Did they test it in a living pig, or just tissue samples?
Mimi
The source says they used ex vivo pig models—tissue samples, not living animals. The living tests were in rats.
Mark
So what's the actual advantage over a traditional pacemaker?
Mimi
No surgery. No wires threaded into the heart. No pulse generator implanted under your skin. No repeat procedures to manage or replace hardware. It's a patch on your chest.
Luke
But you need genetic modification of your heart cells first. That's not nothing. And this is still experimental—not approved for humans, not tested in humans.
Mimi
Right. The researchers did safety testing in rats over eight months, but that's very different from human clinical trials. They're clear about that.
Mark
When might this actually be available to patients?
Mimi
That's unknown. They'd need extensive additional research, clinical trials, and regulatory approval. Years away, at minimum.
Luke
And there's still the question of how you'd actually modify a patient's heart cells in the first place. The proof of concept works, but the practical path to a human treatment isn't clear yet.
Il Polso
- Conventional pacemakers save lives but carry real costs — surgical implantation, hardware that can shift or fail, and follow-up procedures that accumulate over a patient's lifetime.
- A research team has built a wearable chest patch that uses focused ultrasound and sonogenetics to trigger heartbeats in genetically modified cardiac cells, successfully restoring normal rhythm in rats with irregular heartbeats.
- The precision required is extraordinary: the system must locate and stimulate a moving target buried beneath layers of tissue to within less than one millimetre, at frequencies up to 9 Hz, without misdirecting a pulse that could itself cause harm.
- The path to human use remains long and uncertain — target heart cells must be genetically altered to respond to ultrasound, and neither rat trials nor pig tissue experiments constitute proof of human safety or efficacy.
- If the barriers can be crossed, the technology could do more than pace — a future wearable might continuously monitor cardiac rhythm, detect arrhythmias, and respond automatically, all from outside the body.
For generations, the pacemaker has meant surgery — a device buried beneath skin, wires threaded into the beating heart. Researchers at the University of Southern California and MIT have now demonstrated, in animal models, that sound itself may one day serve as the stimulus, using focused ultrasound to coax genetically modified heart cells into rhythm without a single incision. The work, published in Nature Biomedical Engineering, does not yet promise a clinical revolution, but it asks a question that medicine has rarely been positioned to ask: what if the most intimate interventions no longer required entry into the body at all?
A patient arrives with an irregular heartbeat, and today the answer is almost always the same: a small incision, a pulse generator implanted beneath the skin, electrical leads threaded into the heart. It works, but it is invasive, and the hardware demands a relationship — follow-up visits, replacement procedures, the possibility of failure. Researchers at the University of Southern California, MIT, and collaborating institutions have begun to imagine a different answer.
Their experimental device, called a non-invasive ultrasound pacemaker, is a small patch worn on the chest. Rather than delivering electrical impulses through implanted wires, it sends focused sound waves through tissue to reach the heart. The mechanism depends on sonogenetics: heart muscle cells are genetically modified to carry a mechanosensitive ion channel that responds to ultrasound. When the sound waves arrive, the channels open, calcium flows in, and the heart contracts. In rats with abnormal rhythms, the system successfully restored normal sinus rhythm. Additional experiments using pig tissue explored whether the approach could scale toward the human heart. The findings were published in Nature Biomedical Engineering.
The engineering required to make this work is formidable. The heart is a moving target buried beneath skin, fat, and muscle. The researchers addressed this by integrating ultrasound imaging with stimulation, allowing the system to locate its target and deliver a focused pulse with spatial precision under one millimetre. Timing is not incidental — a misdirected or poorly timed stimulus could be dangerous rather than therapeutic.
The distance between this proof of concept and a device available to patients remains vast. The genetic modification of heart cells required for the technology to function presents its own regulatory and safety questions, and neither animal trials nor tissue experiments can substitute for human clinical data. No cardiologist will be offering an ultrasound patch as an alternative to a conventional pacemaker anytime soon.
What the research does offer is a reframing of the question. Implanted cardiac devices have transformed care for people with rhythm disorders, but implantation itself carries risks that accumulate over time. A system that monitors, detects, and responds to arrhythmias entirely from outside the body — without surgery, without hardware inside the chest — would change the nature of that relationship. The researchers have not yet built that system. They have demonstrated that the underlying idea is not impossible.
A cardiologist's patient arrives for a routine checkup with an irregular heartbeat. Today, the standard answer is surgery: a small incision, a pulse generator implanted beneath the skin, electrical wires threaded into the heart itself. It is effective, but it is invasive. It requires follow-up procedures. The hardware can fail or shift. What if none of that were necessary?
Researchers at the University of Southern California, MIT, and collaborating institutions have moved closer to answering that question. They have developed an experimental wearable pacemaker that uses focused ultrasound instead of electricity to regulate the heart's rhythm. The device, called a non-invasive ultrasound pacemaker or NUP, is designed as a small patch that adheres to the chest and sends sound waves through tissue to reach the heart muscle. In tests on rats with abnormal heartbeats and in experiments using pig tissue, the system successfully restored normal rhythm. The findings were published in Nature Biomedical Engineering.
The mechanism is unfamiliar to anyone who has encountered a conventional pacemaker. Traditional devices work by delivering electrical impulses through leads positioned inside or near the heart, connected to a generator implanted under the skin. The new system relies on a technique called sonogenetics. The researchers genetically modified heart muscle cells, known as cardiomyocytes, to express a mechanosensitive ion channel called MscL-G22S. When focused ultrasound reaches these modified cells, the mechanical force causes the channels to open. Calcium ions flow in, triggering the contraction that makes the heart beat. Sound waves, in other words, become the stimulus.
The engineering challenge is considerable. The heart moves constantly and sits beneath layers of skin, fat, and muscle. Sound waves must reach not just the heart, but the precise region where stimulation is needed. The researchers addressed this by combining ultrasound stimulation with imaging. Their wearable system can identify the target region and direct focused ultrasound toward it with spatial precision of less than one millimetre. The system can control stimulation frequencies up to 9 Hz. In rats, this precision allowed researchers to restore normal sinus rhythm when the animals' hearts were beating irregularly. Timing and accuracy matter because a poorly timed or misdirected stimulus could be ineffective or dangerous.
But the distance between a successful animal trial and a device available to patients is vast. The researchers conducted safety testing in rats over an eight-month period during daily activities and performed additional experiments using tissue from pigs to examine whether the technology could work at a scale closer to the human heart. Neither of these steps proves safety or effectiveness in humans. There is also a fundamental barrier: the target heart cells must be genetically modified to respond to ultrasound. The researchers investigated the genetic safety of their approach, but moving to human treatment would require extensive additional research, clinical trials, and regulatory approval.
The potential, however, is significant. Implanted cardiac devices have transformed treatment for people with certain rhythm disorders, but implantation itself carries risks. Leads can malfunction. Hardware can shift. Patients often need additional procedures to manage or replace their devices. A genuinely non-invasive system could eliminate those complications. Because the experimental device combines stimulation with imaging, it could eventually do more than simply deliver a stimulus. A future wearable could monitor cardiac activity, detect abnormal rhythms, and respond automatically—all from outside the body, all without surgery.
For now, this remains early-stage research. No patient should expect their cardiologist to offer an ultrasound patch as an alternative to a conventional pacemaker. The technology has not yet made that leap from laboratory to clinic. What the researchers have demonstrated is a proof of concept that raises a larger question: what does the future of cardiac pacing look like when the device no longer has to be inside the body?
Citazioni salienti
The researchers were able to control cardiac activity and restore normal heart rhythm in rats with abnormal heartbeats— Nature Biomedical Engineering study findings
Success in laboratory models and animals does not establish that the technology is safe or effective in humans— Research team, as reported
Vuoi la storia completa?
Leggi l'originale su Vanguard News ↗
Health & Medicine